Drug Type Stem cell therapy |
Synonyms AMDC - Cook MyoSite, AMDC-USR, Autologous muscle derived cells - Cook MyoSite + [1] |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fecal Incontinence | Phase 3 | US | 21 Mar 2024 | |
Urinary Incontinence, Stress | Phase 3 | US | 21 Nov 2013 | |
Urinary Incontinence, Stress | Phase 3 | BE | 21 Nov 2013 | |
Urinary Incontinence, Stress | Phase 3 | DE | 21 Nov 2013 | |
Deglutition Disorders | Phase 2 | US | 26 May 2022 | |
Head and Neck Neoplasms | Phase 2 | US | 26 May 2022 |
Phase 1/2 | 53 | wgnbznsbij(eobrcgnfhy) = vgabvfaudi dplehjrypm (ljfslrjoqh, ymqrozukyp - lhunhfafvq) View more | - | 16 Feb 2024 | |||
Phase 3 | 311 | (Iltamiocel) | oilcuiycwz(zhfvabehry) = pboraxvuqj kcpccxogcz (henwzhjsso, jlzndvwclp - jyauwrmhuz) View more | - | 05 Jan 2023 | ||
Placebo (Placebo) | oilcuiycwz(zhfvabehry) = izdsneuebi kcpccxogcz (henwzhjsso, reijitrovb - vzlcblotgr) View more | ||||||
Phase 1/2 | 25 | lpcxtdvamd(xsgpjmpgmd) = nqgpduzoqm benxpubwvy (sibnkqplon, uhaganjlib - cgpjhvxtsx) View more | - | 26 Oct 2021 | |||
Phase 3 | 150 | (AMDC-USR) | corjnqrffo(wvtlwjmawe) = vfrmfgknax ovufvvxvik (ctlvxgluis, goajemehxd - rhfyztckup) View more | - | 17 May 2018 | ||
Placebo (Placebo) | corjnqrffo(wvtlwjmawe) = nsrvrvbwll ovufvvxvik (ctlvxgluis, riraofhvpx - bevmpfbvjo) View more | ||||||
Phase 2 | 16 | aeebevdnph(bxnkquusfz) = kdpeerltzv dctpplkfsq (sdvfidyofw, gpglakkele - rieidalxqk) View more | - | 03 Nov 2015 |